Cilastatin / imipenem Alternatives Compared
| Cilastatin / imipenem | Nitrofurantoin | Ciprofloxacin |
|
|---|
| Cilastatin / imipenem | Nitrofurantoin | Ciprofloxacin |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Bacterial Infection, Bacteremia, Aspiration Pneumonia, Bone infection, Bronchitis, Deep Neck Infection, Endocarditis, Endometritis, Febrile Neutropenia, Intraabdominal Infection, Joint... View more |
Prescription only
Nitrofurantoin is an effective antibiotic with a low risk of inducing bacterial resistance that is used specifically to treat urinary tract infections caused by susceptible bacteria. Long-term use... View more |
Prescription only
Ciprofloxacin is an effective antibiotic that treats a wide variety of infections; however, it should not be given to children aged less than 18 and in adults, it should be reserved for infections... View more |
Related suggestions Urinary Tract Infection
|
|||||||||||||||||||||||
| More about Cilastatin / imipenem | More about Nitrofurantoin | More about Ciprofloxacin | ||||||||||||||||||||||||
| Generic Status | ||||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Cilastatin / imipenem has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Nitrofurantoin has an average rating of 4.3 out of 10 from a total of 1801 ratings on Drugs.com. 28% of reviewers reported a positive effect, while 54% reported a negative effect. |
Ciprofloxacin has an average rating of 5.0 out of 10 from a total of 910 ratings on Drugs.com. 37% of reviewers reported a positive effect, while 47% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
|
See also: cilastatin / imipenem side effects in more detail. |
See also: nitrofurantoin side effects in more detail. |
Commonly reported side effects include:
See also: ciprofloxacin side effects in more detail. |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all cilastatin / imipenem prices |
View all nitrofurantoin prices |
View all ciprofloxacin prices |
||||||||||||||||||||||||
| Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Primaxin IV | Furadantin, Macrobid, Macrodantin | Cipro, Cipro Cystitis Pack, Cipro I.V., Cipro XR | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
1 hour |
1 hour |
4 hours |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 35 drugs are known to interact with cilastatin / imipenem:
|
A total of 183 drugs are known to interact with nitrofurantoin:
|
A total of 634 drugs are known to interact with ciprofloxacin:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
N/A |
May 11, 2011 |
March 05, 2014 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.